We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$44.4B
1-Year Est. Return
36.05%
This Fund
S&P 500
This Quarter
Est. Return
+11.33%
1 Year Est. Return
+36.05%
3 Year Est. Return
+84.6%
5 Year Est. Return
+116.4%
10 Year Est. Return
+513.43%
AUM
$33.2B
AUM Growth
+$1.51B
(+4.8%)
Cap. Flow
-$835M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
38.35%
Holding
705
New
90
Increased
190
Reduced
272
Closed
97
Avg Time Held Equity + Options
9.9
quarters
Top 10 Avg Time Held Equity + Options
12.4
quarters
Top 20 Avg Time Held Equity + Options
21.8
quarters
Avg Time Held Equity only
10
quarters
Top 10 Avg Time Held Equity only
12.4
quarters
Top 20 Avg Time Held Equity only
21.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$287M |
| 2 |
Tradeweb Markets
TW
|
+$207M |
| 3 |
Constellation Brands
STZ
|
+$187M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$165M |
| 5 |
Meta Platforms (Facebook)
META
|
+$99.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$526M |
| 2 |
Visa
V
|
+$191M |
| 3 |
Apple
AAPL
|
+$144M |
| 4 |
Oracle
ORCL
|
+$57.6M |
| 5 |
Elevance Health
ELV
|
+$47.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.78% |
| 2 | Healthcare | 21.92% |
| 3 | Financials | 11.41% |
| 4 | Communication Services | 10.63% |
| 5 | Consumer Discretionary | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.97T
| $2.42B | 7.27% |
4,859,939
+76,854
| +2% | +$33.4M |
2013 Q2
48 quarters
|
|
|
2
Meta Platforms (Facebook)
META
$1.83T
| $1.64B | 4.94% |
2,226,027
+160,575
| +8% | +$99.2M |
2018 Q1
29 quarters
|
|
3
Alphabet (Google) Class A
GOOGL
$4.3T
| $1.38B | 4.16% |
7,853,396
+19,435
| +0.2% | +$3.18M |
2015 Q4
38 quarters
|
|
|
4
Oracle
ORCL
$429B
| $1.25B | 3.76% |
5,708,423
-356,434
| -6% | -$57.6M |
2013 Q2
48 quarters
|
|
|
5
Apple
AAPL
$4.91T
| $1.23B | 3.69% |
5,974,046
-711,528
| -11% | -$144M |
2013 Q2
48 quarters
|
|
6
Abbott
ABT
$172B
| $1.06B | 3.2% |
7,814,538
-293,045
| -4% | -$38.6M |
2013 Q2
48 quarters
|
|
7
Johnson & Johnson
JNJ
$630B
| $1B | 3.01% |
6,554,431
-258,356
| -4% | -$39.7M |
2013 Q2
48 quarters
|
|
8
Texas Instruments
TXN
$259B
| $958M | 2.88% |
4,615,305
+65,060
| +1% | +$11.5M |
2016 Q2
36 quarters
|
|
9
Lam Research
LRCX
$399B
| $942M | 2.83% |
9,677,640
+1,084,306
| +13% | +$86M |
2019 Q3
23 quarters
|
|
|
10
Visa
V
$724B
| $861M | 2.59% |
2,426,068
-548,761
| -18% | -$191M |
2017 Q3
31 quarters
|
|
|
11
Broadcom
AVGO
$1.73T
| $844M | 2.54% |
3,063,199
+1,323,637
| +76% | +$287M |
2021 Q1
17 quarters
|
|
12
Salesforce
CRM
$189B
| $806M | 2.43% |
2,957,475
+290,665
| +11% | +$77.7M |
2020 Q3
19 quarters
|
|
|
13
Elevance Health
ELV
$89.5B
| $794M | 2.39% |
2,040,110
-118,881
| -6% | -$47.8M |
2013 Q2
48 quarters
|
|
14
Accenture
ACN
$128B
| $792M | 2.38% |
2,648,564
+208,816
| +9% | +$63.6M |
2013 Q2
48 quarters
|
|
15
Amazon
AMZN
$2.83T
| $791M | 2.38% |
3,605,807
+169,835
| +5% | +$33.6M |
2018 Q3
27 quarters
|
|
|
16
Thermo Fisher Scientific
TMO
$243B
| $751M | 2.26% |
1,851,305
+395,225
| +27% | +$165M |
2024 Q2
4 quarters
|
|
17
US Bancorp
USB
$88.9B
| $750M | 2.26% |
16,569,422
+585,968
| +4% | +$24.6M |
2017 Q2
32 quarters
|
|
18
Wells Fargo
WFC
$253B
| $679M | 2.04% |
8,469,766
+88,358
| +1% | +$6.37M |
2017 Q3
31 quarters
|
|
19
UnitedHealth
UNH
$340B
| $668M | 2.01% |
2,141,448
-82,898
| -4% | -$31.7M |
2013 Q2
48 quarters
|
|
|
20
Constellation Brands
STZ
$20.8B
| $598M | 1.8% |
3,675,855
+1,042,904
| +40% | +$187M |
2021 Q2
16 quarters
|
|
21
Intuitive Surgical
ISRG
$150B
| $592M | 1.78% |
1,089,281
+15,541
| +1% | +$8.13M |
2022 Q2
12 quarters
|
|
22
Hilton Worldwide
HLT
$73.5B
| $532M | 1.6% |
1,996,049
+34,617
| +2% | +$8.24M |
2020 Q2
20 quarters
|
|
23
Merck
MRK
$359B
| $512M | 1.54% |
6,469,573
-217,023
| -3% | -$17.3M |
2016 Q3
35 quarters
|
|
24
Cigna
CI
$74.6B
| $510M | 1.54% |
1,543,978
-44,885
| -3% | -$14.5M |
2020 Q4
18 quarters
|
|
25
Uber
UBER
$146B
| $506M | 1.52% |
5,427,836
+923,409
| +21% | +$76M |
2025 Q1
1 quarter
|
|
Similar funds
GAM
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2025 Portfolio in Review
As of Q2 2025, Grantham, Mayo, Van Otterloo & Co (GMO) held 705 positions worth $33.2B, up 4.8% from $31.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2025 filing shows 90 new, 190 increased, 272 reduced and 97 closed positions. Its largest new stake was Tradeweb Markets: 1,483,629 shares worth $217M. The largest sale was Otis Worldwide, an estimated $526M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2025 buy was Tradeweb Markets: 1,483,629 shares worth $217M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Broadcom in Q2 2025, an estimated $287M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2025 reduction was Otis Worldwide, cutting an estimated $526M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Saia in Q2 2025, selling an estimated $41.2M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 38% of its $33.2B portfolio in Q2 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 90 new positions and closed 97 in Q2 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 4.8% quarter-over-quarter to $33.2B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.